Computer-Aided Strategies for Determining the Amino Acid Composition of Medium for Chinese Hamster Ovary Cell-Based Biomanufacturing Platforms.
Chinese hamster ovary
amino acid
biologics
biomanufacturing
design of experiments
heterologous expression
medium development
metabolic models
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
02 Nov 2019
02 Nov 2019
Historique:
received:
08
10
2019
revised:
30
10
2019
accepted:
31
10
2019
entrez:
6
11
2019
pubmed:
7
11
2019
medline:
31
3
2020
Statut:
epublish
Résumé
Chinese hamster ovary (CHO) cells are used for the production of the majority of biopharmaceutical drugs, and thus have remained the standard industry host for the past three decades. The amino acid composition of the medium plays a key role in commercial scale biologics manufacturing, as amino acids constitute the building blocks of both endogenous and heterologous proteins, are involved in metabolic and non-metabolic pathways, and can act as main sources of nitrogen and carbon under certain conditions. As biomanufactured proteins become increasingly complex, the adoption of model-based approaches become ever more popular in complementing the challenging task of medium development. The extensively studied amino acid metabolism is exceptionally suitable for such model-driven analyses, and although still limited in practice, the development of these strategies is gaining attention, particularly in this domain. This paper provides a review of recent efforts. We first provide an overview of the widely adopted practice, and move on to describe the model-driven approaches employed for the improvement and optimization of the external amino acid supply in light of cellular amino acid demand. We conclude by proposing the likely prevalent direction the field is heading towards, providing a critical evaluation of the current state and the future challenges and considerations.
Identifiants
pubmed: 31684012
pii: ijms20215464
doi: 10.3390/ijms20215464
pmc: PMC6862603
pii:
doi:
Substances chimiques
Amino Acids
0
Biocompatible Materials
0
Culture Media
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Bill and Melinda Gates Foundation
ID : OPP1144
Organisme : Leverhulme Trust
ID : ECF-2016-681
Références
Biotechnol Prog. 2007 Nov-Dec;23(6):1261-9
pubmed: 17949105
Biotechnol Bioeng. 2011 May;108(5):1078-88
pubmed: 21165902
PLoS One. 2015 Sep 02;10(9):e0136815
pubmed: 26331955
Biotechnol J. 2018 Mar;13(3):e1700499
pubmed: 29393587
J Biotechnol. 2013 Apr 15;164(4):469-78
pubmed: 23403402
Biotechnol Prog. 2013 Jan-Feb;29(1):186-96
pubmed: 23143896
Bioprocess Biosyst Eng. 2008 Oct;31(6):569-77
pubmed: 18253755
Biotechnol Bioeng. 2018 Dec;115(12):2908-2929
pubmed: 29987891
Ther Drug Monit. 2017 Aug;39(4):308-315
pubmed: 28230618
Comput Struct Biotechnol J. 2017 Jan 28;15:212-221
pubmed: 28228925
FEBS Lett. 2013 Sep 2;587(17):2832-41
pubmed: 23831062
Bioengineering (Basel). 2014 Oct 01;1(4):188-212
pubmed: 28955024
Appl Microbiol Biotechnol. 2014 Feb;98(4):1771-83
pubmed: 24362913
J Biotechnol. 2013 Dec;168(4):543-51
pubmed: 24056080
Biotechnol Prog. 2016 Sep;32(5):1324-1335
pubmed: 27390260
Biomed Res Int. 2015;2015:598721
pubmed: 25685797
Biotechnol Prog. 2018 Nov;34(6):1407-1426
pubmed: 30290072
Metabolomics. 2015;11(6):1690-1701
pubmed: 26491422
Metab Eng. 2017 Jan;39:117-127
pubmed: 27845184
BMC Syst Biol. 2019 Jan 9;13(1):2
pubmed: 30626386
Bioprocess Biosyst Eng. 2020 Aug;43(8):1381-1389
pubmed: 32211960
Trends Biochem Sci. 2018 Oct;43(10):752-789
pubmed: 30177408
Biotechnol Prog. 2011 Sep-Oct;27(5):1197-205
pubmed: 21618458
Nat Biotechnol. 2018 Dec 6;36(12):1136-1145
pubmed: 30520869
PLoS Comput Biol. 2019 Apr 22;15(4):e1006971
pubmed: 31009451
Biotechnol Prog. 2014 May-Jun;30(3):535-46
pubmed: 24692260
Microbiology (Reading). 2017 Jun;163(6):829-839
pubmed: 28635591
Biotechnol Prog. 2013 May-Jun;29(3):745-53
pubmed: 23606649
Regen Med. 2016 Apr;11(3):287-305
pubmed: 26979513
Cytotechnology. 2015 Oct;67(5):809-20
pubmed: 24798809
J Chromatogr A. 2013 Apr 5;1284:17-27
pubmed: 23453463
Cell Syst. 2016 Nov 23;3(5):434-443.e8
pubmed: 27883890
PLoS One. 2015 Oct 19;10(10):e0140597
pubmed: 26480023
Cell. 2017 Mar 9;168(6):960-976
pubmed: 28283069
Biotechnol J. 2016 Jul;11(7):899-909
pubmed: 27067803
Biotechnol Bioeng. 2017 Nov;114(11):2605-2615
pubmed: 28691262
Metab Eng. 2014 Jul;24:38-60
pubmed: 24747045
Appl Microbiol Biotechnol. 2019 Oct;103(20):8315-8326
pubmed: 31418052
Metab Eng Commun. 2018 Dec 25;8:e00083
pubmed: 30809468
J Chromatogr A. 2019 Jul 5;1596:104-116
pubmed: 30885400
Curr Protoc Protein Sci. 2019 Feb;95(1):e77
pubmed: 30265450
PLoS Comput Biol. 2019 Jul 11;15(7):e1007084
pubmed: 31295267
Metab Eng. 2019 Jan;51:9-19
pubmed: 30227251
Biotechnol Adv. 2018 Jul - Aug;36(4):1328-1340
pubmed: 29738813
Biotechnol Prog. 2000 Jan-Feb;16(1):69-75
pubmed: 10662492
J Biosci Bioeng. 2016 Jul;122(1):117-24
pubmed: 26803706
Integr Biol (Camb). 2015 Aug;7(8):844-5
pubmed: 26198436
Metab Eng. 2019 Jul;54:54-68
pubmed: 30851381
Cytotechnology. 2007 May;54(1):57-68
pubmed: 19003018
Cytotechnology. 2016 Aug;68(4):1287-300
pubmed: 26091615
Biotechnol Bioeng. 2004 Jan 20;85(2):177-84
pubmed: 14705000
Metab Eng. 2011 Sep;13(5):598-609
pubmed: 21821143
Curr Opin Microbiol. 2018 Oct;45:8-15
pubmed: 29367175
Amino Acids. 2016 May;48(5):1161-71
pubmed: 26832172
Biotechnol Bioeng. 2012 Jun;109(6):1415-29
pubmed: 22252269
Nat Biotechnol. 2010 Mar;28(3):245-8
pubmed: 20212490
Metab Eng. 2010 Mar;12(2):161-71
pubmed: 19833223
Biotechnol Prog. 2011 Nov-Dec;27(6):1709-17
pubmed: 21901863
Biotechnol Bioeng. 2015 Mar;112(3):521-35
pubmed: 25220616
Biotechnol Bioeng. 2011 Jan;108(1):82-92
pubmed: 20672285
Biosci Rep. 2018 Nov 23;38(6):
pubmed: 30341247
J Biotechnol. 2005 Aug 22;118(3):316-27
pubmed: 16019100